Dr. Neda Hashemi Sadraei
Claim this profileUniversity of New Mexico Cancer Center
Area of expertise
Bladder Cancer
Neda Hashemi Sadraei has run 5 trials for Bladder Cancer. Some of their research focus areas include:
Prostate Adenocarcinoma
Neda Hashemi Sadraei has run 4 trials for Prostate Adenocarcinoma. Some of their research focus areas include:
Affiliated Hospitals
University Of New Mexico Cancer Center
Presbyterian Kaseman Hospital
Clinical Trials Neda Hashemi Sadraei is currently running
Relugolix + Radiation
for Advanced-Stage Prostate Cancer
This phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with castration-sensitive prostate cancer that has spread to limited other parts of the body (oligometastatic). Relugolix is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body. It may stop the growth of cancer cells that need testosterone to grow. Radiation therapy uses high-energy x rays or protons to kill tumor cells. The addition of relugolix to the radiation may reduce the chance of oligometastatic prostate cancer spreading further.
Recruiting
0 awards
Phase 2
Data Collection
for Cancer Immunotherapy Side Effects
This trial collects research data and samples from patients who experience immunotherapy side effects to store for use in future research studies. Studying research data and samples from patients who experience immunotherapy side effects may help researchers better understand how to predict, prevent, and treat these side effects.
Recruiting
1 award
N/A
7 criteria
More about Neda Hashemi Sadraei
Clinical Trial Related
5 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Neda Hashemi Sadraei has experience with
- Nivolumab
- Pembrolizumab
- Radiation Therapy
- Avelumab
- Durvalumab
- Ipilimumab
Breakdown of trials Neda Hashemi Sadraei has run
Bladder Cancer
Prostate Adenocarcinoma
Cancer
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Neda Hashemi Sadraei specialize in?
Neda Hashemi Sadraei focuses on Bladder Cancer and Prostate Adenocarcinoma. In particular, much of their work with Bladder Cancer has involved Stage IV patients, or patients who are Stage III.
Is Neda Hashemi Sadraei currently recruiting for clinical trials?
Yes, Neda Hashemi Sadraei is currently recruiting for 5 clinical trials in Albuquerque New Mexico. If you're interested in participating, you should apply.
Are there any treatments that Neda Hashemi Sadraei has studied deeply?
Yes, Neda Hashemi Sadraei has studied treatments such as Nivolumab, Pembrolizumab, Radiation Therapy.
What is the best way to schedule an appointment with Neda Hashemi Sadraei?
Apply for one of the trials that Neda Hashemi Sadraei is conducting.
What is the office address of Neda Hashemi Sadraei?
The office of Neda Hashemi Sadraei is located at: University of New Mexico Cancer Center, Albuquerque, New Mexico 87106 United States. This is the address for their practice at the University of New Mexico Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.